Wikipedia
Next stop: Beacon Hill.
Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.
advertisement
But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Why failed clinical trials don’t always spell doom for a new drug
Next article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Medicare proposal to cover medical devices draws a mixed reaction
